News
-
-
-
-
-
-
-
PRESS RELEASE
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth
Zomedica Corp. reports record third-quarter revenue growth of 10%, driven by strong performance in Diagnostics and Capital segments. International expansion and positive outlook for 2025 highlighted by CEO Larry Heaton -
-
PRESS RELEASE
Alphinat Announces a Loss of ($10 856) for Quarter Ended November 30, 2023
Alphinat Inc. reports net loss for Q1 2024, focusing on public sector sales & 6 main solution deliveries. Financial statements available on SEDAR. About Alphinat: making app dev easy with SmartGuide® low-code platform -